IBOGF (Universal Ibogaine) Ending Cash Position: $0.09 Mil (As of Apr. 2025)


What is Universal Ibogaine Ending Cash Position?

Universal Ibogaine IBOGF -1.07% Ending Cash Position is $0.09 Mil as of Apr. 2025.

Universal Ibogaine's Ending Cash Position for the quarter that ended in Apr. 2025 was $0.09 Mil.

Universal Ibogaine's quarterly Ending Cash Position increased from Oct. 2024 ($0.07 Mil) to Jan. 2025 ($0.19 Mil) but then declined from Jan. 2025 ($0.19 Mil) to Apr. 2025 ($0.09 Mil).

Universal Ibogaine's annual Ending Cash Position declined from Jul. 2022 ($0.56 Mil) to Jul. 2023 ($0.24 Mil) but then increased from Jul. 2023 ($0.24 Mil) to Jul. 2024 ($0.27 Mil).

Universal Ibogaine Ending Cash Position Related Terms

Universal Ibogaine Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Ending Cash Position Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Ending Cash Position
Get a 7-Day Free Trial 0.05 1.73 0.56 0.24 0.27

Universal Ibogaine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.27 0.07 0.19 0.09

Universal Ibogaine Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Universal Ibogaine's Ending Cash Position for the fiscal year that ended in Jul. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.23+0.041
=0.27

Universal Ibogaine's Ending Cash Position for the quarter that ended in Apr. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.197+-0.105
=0.09

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.09 Mil mean?
Universal Ibogaine (IBOGF) has a Ending Cash Position of $0.09 Mil as of Apr. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Universal Ibogaine and its competitors.
Is Universal Ibogaine's Ending Cash Position too high?
Universal Ibogaine's current Ending Cash Position is $0.09 Mil.
How does Universal Ibogaine's Ending Cash Position compare to LABT and CALC?
Universal Ibogaine's Ending Cash Position of $0.09 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Universal Ibogaine and its competitors. Universal Ibogaine's current Ending Cash Position is $0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (IBOGF) has a current Ending Cash Position of $0.09 Mil. The current Ending Cash Position is $0.09 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current Ending Cash Position is $0.09 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.